Menu Search
Equities

Neogen Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
NG2:STU

Neogen Corp

Actions
  • Price (EUR)9.15
  • Today's Change0.150 / 1.67%
  • Shares traded0.00
  • 1 Year change-10.29%
  • Beta1.9497
Data delayed at least 15 minutes, as of Feb 06 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Neogen Corporation and subsidiaries are engaged in developing, manufacturing and marketing a diverse line of products and services dedicated to food and animal safety. The Company has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. Its segments include Food Safety and Animal Safety. The Food Safety segment is primarily engaged in the development, production and marketing of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation. The Animal Safety segment is primarily engaged in the development, production and marketing of products dedicated to animal safety, including a complete line of consumable products marketed to veterinarians and animal health product distributors. This segment also provides genomic identification and related interpretive bioinformatic services.

  • Revenue in USD (TTM)880.32m
  • Net income in USD-602.74m
  • Incorporated1981
  • Employees2.97k
  • Location
    Neogen Corp620 Lesher PlLANSING 48912-1509United StatesUSA
  • Phone+1 (517) 372-9200
  • Fax+1 (517) 372-2006
  • Websitehttps://www.neogen.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.